• TREATMENT

    Local therapy use for metastatic CRC increased, with 5-year survival at 50% for liver metastases

    A Norwegian population study of 20,210 metastatic colorectal cancer patients found that 21% received local therapy (surgery, stereotactic radiotherapy, or ablation), with 5-year overall survival of 50% for liver metastases, 62% for lung, and 5% for brain. (JCO Oncology Practice)